NCT00053027View on ClinicalTrials.gov

Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

November 30, 2009

Conditions
Lymphoma
Interventions
BIOLOGICAL

rituximab

DRUG

cladribine

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00053027 - Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter